Table 3. Tumour stage according to neoadjuvant chemotherapy administration in patients who had received radical surgery.

Variable	No. of patients (n=67) (%)
Pre-chemotherapy TNM
T1–2N−	5 (7.5)
T1–2N+	4 (6.0)
T3–4N−	17 (25.4)
T3–4N+	41 (61.2)
Post-chemotherapy TNM
T0–N0	0
T1–2N−	10 (14.9)
T1–2N+	8 (11.9)
T3–4N−	24 (35.8)
T3–4N+	25 (37.3)
ypTNM
T0–N0	2 (3.0)
T1–2N0	9 (13.4)
T1–2N1–3	8 (11.9)
T3–4N0	20 (29.8)
T3–4N1–3	28 (41.8)